Erin Sivyer Lee is the CEO of Flow Neuroscience, a Swedish company that is transforming the way we understand and treat the brain via at home brain stimulation. Flow's first product, Flow for Depression, has more than 50,000 users across Europe, is prescribed by more than 600 clinicians and is used in multiple NHS trusts. A US launch is planned for H1 2026. Flow is rapidly establishing a new paradigm for the treatment of depression through the first at-home alternative to antidepressants in 35 years, with expansion to additional indications like bipolar, addiction and TBI underway. Prior to joining Flow in 2022, Erin led global operations at digital health provider Babylon Health. She also held leadership roles at Uber, focused on growing the company’s business in Europe and the Middle East, as well as at Google, where she focused on product strategy and innovation.